PEN2 is not a genetic risk factor for Alzheimer’s disease in a large family sample
暂无分享,去创建一个
D. Blacker | R. Tanzi | L. Bertram | K. Mullin | M. Parkinson | R. Menon | M. Bradley
[1] B. Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex , 2003, Neuron.
[2] Christoph Lange,et al. Power calculations for a general class of family-based association tests: dichotomous traits. , 2002, American journal of human genetics.
[3] Wei Xu,et al. aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation , 2002 .
[4] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[5] S. Poduslo,et al. A new locus on chromosome 19 linked with late-onset Alzheimer's disease , 2001, Neuroreport.
[6] Daniel Rabinowitz,et al. A Unified Approach to Adjusting Association Tests for Population Admixture with Arbitrary Pedigree Structure and Arbitrary Missing Marker Information , 2000, Human Heredity.
[7] J. Haines,et al. ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.
[8] M. Albert,et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.
[9] B. de Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. , 2003, Neuron.
[10] M. C. Ellis,et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. , 2002, Developmental cell.